期刊文献+

30%超分子水杨酸联合异维A酸治疗中重度痤疮效果及安全性评价 被引量:1

Efficacy and safety evaluation of 30% supramolecular salicylic acid combined with isotretinoic acid in the treatment of moderate to severe acne
下载PDF
导出
摘要 目的观察30%超分子水杨酸联合异维A酸胶囊口服治疗中重度痤疮的临床效果及安全性评价。方法选择门诊60例中重度痤疮患者为研究对象,随机分为治疗组和对照组,每组各30例。治疗组外用30%超分子水杨酸的同时口服异维A酸胶囊,对照组仅口服异维A酸胶囊。于治疗前及治疗第2、4、6、8周计数皮损、疗效和不良反应。结果治疗组在第2、4、6周疗效明显优于对照组,差异有统计学意义(P<0.05)。常见不良反应中红斑、刺痛的发生率治疗组明显高于对照组,差异有统计学意义(P<0.05),唇炎、皮肤干燥、脱皮及瘙痒发生率差异无统计学意义(P>0.05)。两组均未见严重不良反应。结论30%超分子水杨酸联合异维A酸治疗中重度痤疮临床疗效确切,安全性好。 Objective To observe the clinical efficacy and safety of 30%supramolecular salicylic acid combined with isotretinic acid capsule in the treatment of moderate to severe acne.Methods 60 patients with moderate to severe acne were randomly divided into treatment group and control group with 30 patients in each group.In the treatment group,30%supramolecular salicylic acid was applied externally and isotretinoic acid capsule was given at the same time.In the control group,only isotretinoin capsule was given.Lesions,efficacy and adverse reactions were counted before treatment and at week 2,4,6 and 8 after treatment.Results The curative effect of the treatment group was better than that of the control group at week 2,4 and 6,with statistically significant difference(P<0.05).The incidence of common adverse reactions such as erythema and prickling was significantly higher in the treatment group than in the control group(P<0.05).There was no statistically significant difference in the incidence of labitis,xerosis cutis,peeling and pruritus.There were no serious adverse reactions were observed in either group.Conclusion 30%supramolecular salicylic acid combined with isotretinoic acid is effective and safe in the treatment of moderate to severe acne.
作者 刘颖科 田立红 LIU Ying-ke;TIAN Li-hong(Department of Dermatology,Changsha Central Hospita Affiliateld to Nanhua University,Changsha 410007,China)
出处 《中国处方药》 2021年第4期72-73,共2页 Journal of China Prescription Drug
关键词 超分子水杨酸 异维A酸 中重度痤疮 疗效 安全性 Supramolecular salicylic acid Isotretinoic acid Inmoderate to severe acne Effective rate Safety
  • 相关文献

参考文献6

二级参考文献46

  • 1钟华,何黎,王玮蓁,许爱娥,易东,王莉,周村建,李红宾,徐延华,王向东,黄萌,单筠筠,陈俊帆,郝飞.维胺酯和异维A酸治疗寻常痤疮随机双盲研究[J].中华皮肤科杂志,2006,39(10):574-576. 被引量:16
  • 2Zouboulis CC. Isotretinoin revisited pluripotent effects on humansebaceous gland cells [J]. J Invest Dermatol, 2006, 126 (10):2154-2156.
  • 3On SC, Zeichner J. Isotretinoin updates [J]. Dermatol Ther,2013,26⑶:377-389.
  • 4Nelson AM, Gilliland KL, Cong Z, et al. 13-cis retinoic acidinduces apoptosis and cell cycle arrest in human SEB-1 sebo-cytes[J]. J Invest Dermatol, 2006, 126(10): 2178-2189.
  • 5Tsukada M,Schroder M,Roos TC, et al. 13-cis retinoic acidexerts its specific activity on human sebocytes through selectiveintracellular isomerization to all -trans retinoic acid and bindingto retinoid acid receptors [J]. J Invest Dermatol, 2000, 115(2):321-327.
  • 6Karlsson T, Vahlquist A, Kedishvili N, et al. 13 -cis-retinoicacid competitively inhibits 3 alpha -hydroxysteroid oxidationbyretinol dehydrogenase RoDH-4: a mechanim for its anti-an-drogenic effects in sebaceous glands. [J]. Biochem Biophys ResCommun, 2003, 303(1): 273-278.
  • 7Ganceviciene R, Zouboulis CC. Isotretinoin: state of the arttreatment for acne vulgaris [J]. J Dtsch Dermatol Ges, 2010,8Suppl 1: S47-S59.
  • 8Karadag AS, Ertugrul DT, Bilgili SG, et al. Immunoregulatoryeffects of isotretinoin in patients with acne [J]. Br J Dermatol,2012, 167(2): 433-435.
  • 9Dispenza MC, Wolpert EB, Gilliland KL, et al. Systemicisotretinoin therapy normalizes exaggerated TLR -1 -mediated in-nate immune responses in acne patients [J]. J Invest Dermatol,2012,132(9): 2198-2205.
  • 10Fathy A, Mohamed RW, Ismael NA,et al. Expression of toll-like receptor 2 on peripheral blood monocytes of patients withinflammatory and noninflammatory acne vulgaris[J]. Egypt J Im-munol, 2009, 16(1); 127-134.

共引文献682

同被引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部